文献速递肝病消化道肿瘤与早癌

HFE血色病肝终点外显率的遗传修饰因素:大型社区队列中的关联研究

Genetic modifiers of penetrance to liver endpoints in HFE hemochromatosis: Associations in a large community cohort.
PubMed 文献 · Hepatology · 2022-06-17

研究纳入英国生物银行中1294名男性和1596名女性欧洲血统的HFE p.C282Y纯合子,随访至基线后14年,评估多基因评分是否修饰血色病临床外显率。男性中铁多基因评分最高20%者肝纤维化或肝硬化诊断风险为最低20%者的4.90倍(95%CI 1.63-14.73,p=0.005),并增加肝癌和骨关节炎风险但不增加糖尿病风险;女性中铁多基因评分无稳健关联。

要点

  • 男性p.C282Y纯合子中铁多基因评分最高20% vs 最低20%的肝纤维化或肝硬化OR=4.90(95%CI 1.63-14.73,p=0.005)。
  • 男性中铁多基因评分还增加肝癌和骨关节炎诊断风险,但不增加糖尿病风险。
  • 女性p.C282Y纯合子及其他p.C282Y/p.H63D基因型中铁多基因评分无稳健关联。

核心结论

  • 大型社区队列中HFE p.C282Y纯合子的临床疾病外显率部分由影响铁水平和相关疾病风险的常见遗传变异解释。
  • 作者认为多基因评分用于血色病筛查和诊断可能有助于估计预后和治疗计划。

研究设计与样本

  • 研究纳入英国生物银行中1294名男性和1596名女性欧洲血统的HFE p.C282Y纯合子参与者,医学记录随访至基线评估后14年。
  • 使用多基因评分量化一般人群中血液铁生物标志物和相关疾病的遗传效应。
  • 分析也在其他HFE p.C282Y/p.H63D基因型组中进行。

主要发现

  • 男性p.C282Y纯合子中铁多基因评分最高20% vs 最低20%的肝纤维化或肝硬化诊断OR=4.90(95%CI 1.63-14.73,p=0.005)。
  • 男性p.C282Y纯合子中铁多基因评分还增加肝癌和骨关节炎诊断风险,但不增加糖尿病风险。
  • 男性p.C282Y纯合子中肝硬化多基因评分与肝癌诊断相关。
  • 女性p.C282Y纯合子中骨关节炎多基因评分与骨关节炎诊断增加相关,2型糖尿病多基因评分与糖尿病相关。
  • 女性p.C282Y纯合子或其他p.C282Y/p.H63D基因型中铁多基因评分与诊断无稳健关联。

临床怎么用

  • 作者认为多基因评分用于血色病筛查和诊断可能有助于估计预后和治疗计划。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The iron overload condition hereditary hemochromatosis (HH) can cause liver cirrhosis and cancer, diabetes, and arthritis. Males homozygous for the p.C282Y missense mutation in the Homeostatin Iron Regulator (HFE) gene have greatest risk; yet, only a minority develop these conditions. We aimed to determine whether common genetic variants influencing iron levels or liver disease risk in the general population also modify clinical penetrance in HFE p.C282Y and p.H63D carriers. METHODS: We studied 1294 male and 1596 female UK Biobank HFE p.C282Y homozygous participants of European ancestry with medical records up to 14 years after baseline assessment. Polygenic scores quantified genetic effects of blood iron biomarkers and relevant diseases (identified in the general population). Analyses were also performed in other HFE p.C282Y/p.H63D genotype groups. RESULTS: In male p.C282Y homozygotes, a higher iron polygenic score increased the risk of liver fibrosis or cirrhosis diagnoses (odds ratio for the top 20% of iron polygenic score vs. the bottom 20% = 4.90: 95% confidence intervals, 1.63-14.73; p = 0.005), liver cancer, and osteoarthritis but not diabetes. A liver cirrhosis polygenic score was associated with liver cancer diagnoses. In female p.C282Y homozygotes, the osteoarthritis polygenic score was associated with increased osteoarthritis diagnoses and type-2 diabetes polygenic score with diabetes. However, the iron polygenic score was not robustly associated with diagnoses in p.C282Y female homozygotes or in other p.C282Y/p.H63D genotypes. CONCLUSIONS: HFE p.C282Y homozygote penetrance to clinical disease in a large community cohort was partly explained by common genetic variants that influence iron and risks of related diagnoses in the general population, including polygenic scores in HH screening and diagnosis, may help in estimating prognosis and treatment planning.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Pilling LC, Atkins JL, Melzer D, et al. Genetic modifiers of penetrance to liver endpoints in HFE hemochromatosis: Associations in a large community cohort. Hepatology. 2022. PMID: 35567766. doi:10.1002/hep.32575

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。